Biochemical and immunological aspects of protein aggregation in neurodegenerative diseases (Q57405353)

1

0 references

Naemeh Tavakolinia

2

0 references

Adeleh Divsalar

3

0 references

Thomas Haertlé

4

0 references

Ali Akbar Saboury

5

0 references

Mohsen Nemat-Gorgani

Journal of the Iranian Chemical Society

6

0 references

publication date

10 July 2014

0 references

published in

0 references

volume

11

0 references

issue

6

0 references

page(s)

1503-1512

0 references

cites work

Investigation on the surface hydrophobicity and aggregation kinetics of human calprotectin in the presence of calcium

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Theoretical approaches to protein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

The actin cytoskeleton in spindle assembly and positioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Protein aggregation and bioprocessing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Systemic and acquired immune responses in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Three or more routes for leukocyte migration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Visualising microglial activation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Huntington's Disease: An Immune Perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Innate immunity in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Immunotherapeutic Approaches to Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

A kinetic model for amyloid formation in the prion diseases: importance of seeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Protein-misfolding diseases and chaperone-based therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Protein misfolding, evolution and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Large proteins have a great tendency to aggregate but a low propensity to form amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Principles of protein folding, misfolding and aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Protein aggregation and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Deregulation of sphingolipid metabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Pathways towards and away from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Amyloid beta-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Alzheimer's disease: the lipid connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Nutritional approaches to combat oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Apolipoprotein E alleles as risk factors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Inflammation, autotoxicity and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Immunology and immunotherapy of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Retracted: ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Alzheimer's disease: a review concerning immune response and microischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Role of inflammation in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Inflammation, microglia, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Immunosenescence, inflammation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

The immune system, amyloid-beta peptide, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

The role of neuroimmunomodulation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Immunotherapy for Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Transmissible spongiform encephalopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Toxic proteins in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Novel proteinaceous infectious particles cause scrapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Attempts to release the scrapie agent from tissue debris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Thiocyanate and hydroxyl ions inactivate the scrapie agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Prion protein and the transmissible spongiform encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Normal host prion protein necessary for scrapie-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Purification and structural studies of a major scrapie prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Metal ions and prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Location and properties of metal-binding sites on the human prion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Anchorless prion protein results in infectious amyloid disease without clinical scrapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Prion disease and the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Protein conformation significantly influences immune responses to prion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

A review of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Update on Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Clinical and quantitative pathologic correlates of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Evidence that alpha-synuclein functions as a negative regulator of Ca(++)-dependent alpha-granule release from human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Iron toxicity and oxygen radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

CD 4+ T cells in the pathobiology of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Immunological features of alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Mechanisms underlying inflammation in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Glial reactions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Nitrated alpha-synuclein and microglial neuroregulatory activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

A possible role for humoral immunity in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Loss of normal huntingtin function: new developments in Huntington's disease research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Mitochondrial matters in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

The role of immunity in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Early and progressive accumulation of reactive microglia in the Huntington disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13738-014-0491-X